Pages that link to "Item:Q1731276"
From MaRDI portal
The following pages link to The role of the innate immune system in oncolytic virotherapy (Q1731276):
Displaying 13 items.
- Modeling dynamics of cancer radiovirotherapy (Q827732) (← links)
- Spatial model for oncolytic virotherapy with lytic cycle delay (Q2002116) (← links)
- Natural killer cells recruitment in oncolytic virotherapy: a mathematical model (Q2035789) (← links)
- Basic stochastic model for tumor virotherapy (Q2038825) (← links)
- Deterministic and stochastic modeling for PDGF-driven gliomas reveals a classification of gliomas (Q2047173) (← links)
- Combination of virotherapy and chemotherapy with optimal control for combating cancer (Q2076775) (← links)
- Dynamics of a virological model for cancer therapy with innate immune response (Q2210257) (← links)
- The role of viral infectivity in oncolytic virotherapy outcomes: a mathematical study (Q2240252) (← links)
- Investigation into the role of macrophages heterogeneity on solid tumour aggregations (Q2306288) (← links)
- Hopf bifurcation without parameters in deterministic and stochastic modeling of cancer virotherapy. I (Q2673008) (← links)
- A mathematical study of the role of tbregs in breast cancer (Q2676644) (← links)
- Backward Hopf bifurcation in a mathematical model for oncolytic virotherapy with the infection delay and innate immune effects (Q3304318) (← links)
- On a three-dimensional and two four-dimensional oncolytic viro-therapy models (Q6081467) (← links)
